In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, explains J&J’s ...

Exicure has concluded subject enrolment in its ongoing randomised Phase II trial on GPC-100 (burixafor) in conjunction with ...

Rajavithi Hospital successfully performs stem cell transplant for multiple myeloma patient, marking a major milestone in ...

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

“Historically, diagnosing hematological malignancies has required bone marrow biopsies ... in the diagnosis and prognosis of multiple myeloma, plasma cell malignancies and other blood cancers ...

1 Multiple myeloma originates in blood plasma cells — a type of cell found in bone marrow that is responsible for making antibodies. When these plasma cells become cancerous, they multiply ...